Presentation TCT 2018

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

Presenter: Giuseppe Biondi-Zoccai

September 21, 2018

REGISTER for free or LOG IN to view this content

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

Structural Heart

Presentation

TCT 2018

Aortic Valve

Up Next

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Dean J. Kereiakes

September 21, 2018

More slides +

Presentation TCT 2018

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presenter: Patrick W. Serruys

September 21, 2018

Presentation TCT 2018

TCT-63: Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Michael Haude

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.